Trials / Terminated
TerminatedNCT00343655
Evaluation of Atorvastatin Treatment on Carotid Plaque.
A Randomized Clinical Trial Of Atorvastatin 10 Mg And 80 Mg In The Reversal Of Or Stabilization Of Carotid Atheroma Lipid Pool
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 160 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the effect of 18 months treatment with atorvastatin 80mg or atorvastatin 10mg on the carotid vessel plaque morphology, in particular, the effect on evident necrotic lipid rich core of the plaque in patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin |
Timeline
- Start date
- 2007-01-01
- Completion
- 2007-08-01
- First posted
- 2006-06-23
- Last updated
- 2021-02-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00343655. Inclusion in this directory is not an endorsement.